PavelN.PichurinMD

Clinical Genetics

Assistant Professor, Medical Genetics, Mayo Medical School

Dr. Pichurin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Pavel Pichurin is a medical geneticist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Ural State Medical Academy and has been in practice 23 years. He specializes in clinical genetics.

University of Texas Southwestern Medical CenterResidency, Medical Genetics and Genomics, 2009 - 2011
Cedars-Sinai Medical CenterResidency, Surgery, 2006 - 2008
Ural State Medical AcademyClass of 1994

PubMed

Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic Cardiomyopathy.
Filippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh, Roy B Dyer, Konstantinos C Siontis
Circulation. Heart Failure. 2025-03-31
1 citations
Mayo Clinic Tapestry Study: A Large-Scale Decentralized Whole Exome Sequencing Study for Clinical Practice, Research Discovery, and Genomic Education.
Lorelei A Bandel, Robert A Vierkant, Teresa M Kruisselbrink, Michelle L Bublitz, Tammy A Wilson
Mayo Clinic Proceedings. 2024-11-05
3 citations
Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder.
Patrick R Blackburn, Frédéric Ebstein, Tzung-Chien Hsieh, Marialetizia Motta, Francesca Clementina Radio
Annals of Neurology. 2024-09-20

Journal Articles

Extension of the Mutational and Clinical Spectrum of SOX2 Related Disorders: Description of Six New Cases and a Novel Association with Suprasellar Teratoma
Elizabeth J Bhoj, Rachael A Vaubel, Joseph E Parisi, Pavel N Pichurin, American Journal of Medical Genetics Part A

Genetic Sleuths Dig Deep to Identify a Young Boy’s Rare ConditionFebruary 13th, 2018
Next Generation Sequencing – a Game ChangerMarch 28th, 2017